Clinical Trials Sponsored by Instituto Nacional de Salud

Total 2515 results

Instituto Nacional de Cardiologia Ignacio Chavez
Instituto Nacional de Rehabilitacion

Unknown

Effects of Allopurinol on Inflammation and Ultrasonographic Changes in People With Elevated Uric Acid But no Symptoms

Inflammation | Hyperuricemia | Musculoskeletal Degeneration

Mexico
Instituto de Investigación Hospital Universitario...
Instituto de Salud Carlos III; Spanish Clinical Research Network - SCReN

Active, not recruiting

Vaccination With COMIRNATY in Subjects With a VAXZEVRIA First Dose (CombiVacS)

Covid19

Spain
Global Institute of Probiotics
Dr. C. Bonorino Udaondo Gastroenterology Hospital; Research Institute, Universidad... and other collaborators

Completed

Bifidobacterium Infantis NLS Super Strain for Celiac Disease Patients on a Gluten-free Diet With Persistent Gastrointestinal Symptoms

Celiac Disease

Argentina
Emory University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Effects of Prenatal DHA Supplements on Infant Development

Pregnancy

Mexico
Hospital Clinic of Barcelona
Lundbeck Foundation; Institut Català de la Salut; Public Health Agency of Barcelona and other collaborators

Completed

Impact of Alcohol Consumption on Use of Health Care Resources

Alcohol Consumption

Spain
Instituto Nacional de Cancerologia de Mexico

Recruiting

Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.

Non-small Cell Lung Cancer | Brain Metastases | EGFR Gene Mutation

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Alectinib Pharmacokinetic in Patients With NSCLC

ALK Gene Mutation | Non-small Cell Lung Cancer Stage IIIB

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations (METLUNG)

Non Small Cell Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy

Ovarian Cancer | Chemotherapy Effect | HPEC | Women's Health: Neoplasm of Ovary

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients

Quality of Life | Sarcopenia | Pulmonary Rehabilitation

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC

Lung Cancer | Sarcopenia | Toxicity

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer

Lung Neoplasms | Small Cell Lung Carcinoma | Non-Small Cell Lung Cancer | Taste Disorders | Dysgeusia

Mexico
Instituto Nacional de Cancerologia de Mexico

Terminated

Study of Whole-brain Irradiation With Chloroquine for Brain Metastases (CLQ)

Brain Metastasis

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Prophylactic Cranial Irradiation in Patients With Lung Adenocarcinoma With High Risk of Brain Metastasis (PCI)

Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia

Anorexia | Non-small Cell Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Active, not recruiting

Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest Surgery (AEROBIKA)

Lung Cancer | Mediastinal Tumor | Pleural Tumor

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

MK-3475 in Combination With Docetaxel vs Docetaxel Alone in Non-Small Cell Lung Cancer Patients

Carcinoma, Non-Small-Cell Lung

Mexico
Instituto Nacional de Cardiologia de Laranjeiras

Completed

The Effects of Aerobic Exercise in Microvascular Endothelium Function in Patients With Cardiovascular Diseases

Cardiovascular Diseases

Brazil
Instituto Nacional de Cancerologia de Mexico

Unknown

Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients (SPIROCAN)

Cancer | Critically Ill

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment

Brain Neoplasms

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.

Non-Hodgkin Lymphoma

Mexico
Fundacion para la Investigacion y Formacion en...
Instituto de Investigación Biomédica de Salamanca

Completed

Smartphone Applications to Improve Lifestyles in Olders Over 65 Years (EVIDENT-Age)

Telemedicine

Spain
Fundacion para la Investigacion y Formacion en...
Instituto de Investigación Biomédica de Salamanca

Completed

Intensive Intervention to Improve Lifestyles in Subjects With Intermediate Cardiovascular Risk.

Cardiovascular Risk Factor

Spain
Instituto Nacional de Cancerologia de Mexico

Recruiting

Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients

Hematologic Neoplasms | Neutropenia

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC

Non-Small Cell Lung Cancer With EGFR Mutation

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Ketamine or Placebo in Patients With Major Depression and Advanced Cancer (KODIAC)

Major Depressive Disorder | Advanced Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)

Lung Cancer | Skin Rash

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer.

Quality of Life | Breast Neoplasm | Antineoplastic Agents | Antiemetics

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

ALK Rearrangements in Lung Adenocarcinoma: Epidemiology in Latin America (CLICaP)

Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Early Incorporation of Patient and Family to Attention and Care Program in Oncology Versus Standard of Care (PACO)

Lung Neoplasms

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients

Anorexia | Non-Small Cell Lung Cancer | Cachexia | Weight Lose

Mexico
Hospital Galdakao-Usansolo
Hospital del Mar; Instituto de Salud Carlos III; Hospitales Universitarios Virgen... and other collaborators

Completed

Identification of Multimorbid Patients With a Higher Probability of Readmission and Mortality

Multimorbidity

Spain
Universitat Internacional de Catalunya
Institut Català d'Oncologia; Hospital Arnau de Vilanova; Fundacion Rioja Salud

Not yet recruiting

Efficacy of a Proactive Approach to Death Thoughts in People With Advanced Cancer (Go-TAD)

Death | Advanced Cancer
National Institute of Cancerología
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Instituto...

Recruiting

Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

Cervical Cancer

Mexico
Instituto Nacional de Rehabilitacion

Not yet recruiting

BCI-FES for Upper Limb Rehabilitation in Chronic Stroke (BCI-FES)

Stroke | Upper Extremity Paresis | Neuronal Plasticity

Mexico
Coordinación de Investigación en Salud, Mexico
Universidad Nacional Autonoma de Mexico; Hospital Infantil de Mexico Federico...

Completed

Internet-based Intervention to Prevent Risky Sexual Behaviors in Mexican Adolescents

Adolescent Behavior
Instituto Nacional de Salud Publica, Mexico
Tufts University; Instituto Mexicano del Seguro Social; Ellison Medical / International...

Completed

Vitamin D, C-reactive Protein and Insulin Resistance

Diabetes | Insulin Resistance | Low-intensity Chronic Inflammation

Mexico
Sara V. Latorre
Instituto de Salud Carlos III; Institut d'Investigacions Biomèdiques August...

Active, not recruiting

Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy (CART19-BE-02)

Acute Lymphoid Leukemia

Spain
Sara V. Latorre
Instituto de Salud Carlos III

Completed

Pilot Study on the Infusion of ARI-0001 Cells in Patients With CD19+ Leukemia or Lymphoma Refractory to Therapy (CART19-BE-01)

Lymphoma | Leukemia

Spain
Salvador Sarró, MD
Instituto de Salud Carlos III; Centro de Investigación Biomédica en Red de... and other collaborators

Completed

Effects of a Cognitive Rehabilitation Program: a Neurocognitive Study

Schizophrenia

Spain
Jordi Gol i Gurina Foundation
Institut Catala de Salut

Completed

Effects of a Physical Exercise Program on Patients Affected With Fibromyalgia

Fibromyalgia

Spain
Jordi Gol i Gurina Foundation
Institut Catala de Salut

Completed

Efficiency of Monitoring and Control Program of Hypertension Through Pharmacy Offices. APOF Project (APOF)

Hypertension

Spain
Instituto de Nutrición y Tecnología de los Alimentos
Pontificia Universidad Catolica de Chile; Servicio de Salud Metropolitano Sur...

Active, not recruiting

Chilean Maternal & Infant Cohort Study II (CHiMINCs-II) (CHiMINCs-II)

Nutritional Status | Body Composition | Breast Density | Mental Health Issue

Chile
Instituto Nacional de Cardiologia de Laranjeiras

Recruiting

Cerebral Oxygen Saturation Monitoring In Cardiac Surgery (COSMICS) (COSMICS)

Cognitive Dysfunction | Cardiac Disease

Brazil
Instituto Nacional de Cancerologia de Mexico

Completed

Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer | EGFR | HER-2

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung | Synchronous Neoplasms

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Results From a Mexican Acute Promyelocytic Leukemia. (Mexico APL)

Promyelocytic Leukemia, Acute

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients

Phase II Clinical Trial | Ninety-six Histologically Confirmed NSCLC Patients With BM | Randomized 1:1 to Received TN Plus WBR or Only WBR | ICPFS Evaluated by Two Blinded and Independent Radio-oncologist With MRI

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK) (ALK)

Non Small-cell Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Metformin Plus TKI Use in Patients With Non-Small Cell Lung Carcinoma

EGFR Gene Mutation | Tyrosine Kinase Mutation | Non-Small Cell Adenocarcinoma

Mexico

Clinical Trials Sponsored by Instituto Nacional de Salud

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations